Related references
Note: Only part of the references are listed.Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective
Arthi Reddy et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2020)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T. Dess et al.
JAMA ONCOLOGY (2019)
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Comparison of Wait Times for New Patients Between the Private Sector and United States Department of Veterans Affairs Medical Centers
Madeline Penn et al.
JAMA NETWORK OPEN (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force
Joshua J. Fenton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Ensuring Timely Access to Quality Care for US Veterans
Jennifer Daley
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration
David P. Guo et al.
JOURNAL OF UROLOGY (2018)
Prostate Cancer Outcomes for Men Aged Younger Than 65 Years With Medicaid Versus Private Insurance
Amandeep R. Mahal et al.
CANCER (2018)
Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures
Daniel J. Lee et al.
PRACTICAL RADIATION ONCOLOGY (2018)
Racial disparities in prostate cancer: a molecular perspective
Arun Bhardwaj et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
C. Brooke Steele et al.
CANCER (2017)
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database
Stephen J. Freedland et al.
CANCER (2017)
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
B. A. Mahal et al.
ANNALS OF ONCOLOGY (2017)
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
Kosj Yamoah et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Income inequality and treatment of African American men with high-risk prostate cancer
David R. Ziehr et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark
Vera Ehrenstein et al.
CLINICAL EPIDEMIOLOGY (2015)
Racial differences in time from prostate cancer diagnosis to treatment initiation A Population-Based Study
William A. Stokes et al.
CANCER (2013)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa
Folakemi T Odedina et al.
Infectious Agents and Cancer (2009)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy
Robert J. Hamilton et al.
CANCER (2007)
Assessing prostate cancer risk: Results from the prostate cancer prevention trial
IM Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
